Tiziana Life Sciences (TLSA) Total Liabilities (2017 - 2025)

Tiziana Life Sciences (TLSA) has reported Total Liabilities for 9 consecutive years, with $11.4 million the latest figure, recorded in Q4 2025.

• Quarterly Total Liabilities rose 55.73% year-over-year to $11.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.4 million (up 55.73% YoY) and the FY2025 annual result came in at $11.4 million, up 55.73% from the prior year.
• Total Liabilities advanced to $11.4 million in Q4 2025 per TLSA's latest filing, from $7.4 million in the prior quarter.
• Over the last five years, Total Liabilities for TLSA reached as high as $11.4 million in Q4 2025 and fell as low as $4.1 million in Q2 2023.
• A 5-year average of $7.5 million and a median of $7.4 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities tumbled 42.41% — and 2024, when it surged 120.93%.
• Year by year, Total Liabilities stood at $7.5 million in 2021, then decreased by 8.48% to $6.9 million in 2022, then declined by 3.74% to $6.6 million in 2023, then rose by 10.53% to $7.3 million in 2024, then jumped by 55.73% to $11.4 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $11.4 million, $7.4 million, and $7.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.